A potential COVID-19 vaccine, the first to be developed in India, has been given DCGI (Drug Controller General of India) approval for Phase I and II human clinical trials that are scheduled to start across the country in July. Developed by Hyderabad-based Bharat Biotech, in association with ICMR (Indian Council for Medical Research), COVAXIN is an inactivated vaccine, created from a strain of the infectious SARS-CoV-2 virus, that has shown promise in preclinical studies, demonstrating extensive safety and effective immune responses.
from Videos https://ift.tt/2Ag1JNP
Subscribe to:
Post Comments (Atom)
-
No power supply, a looming food and water crisis, more than 3 lakh people displaced and over 1,100 dead - as Israel strikes backs after Hama...
-
By BY JIM TANKERSLEY AND EMILY COCHRANE from NYT Business https://ift.tt/3jGs75O
No comments:
Post a Comment